Reconstitution and bacteriostatic water: compatibility and checks
Laboratory material for research use only; not intended for human use.
Reconstitution means returning dry material to solution under defined conditions. It does not establish sterility, the intended concentration or preservation of biological activity. Preparing a peptide requires matching the molecule, vehicle composition and final assay requirements. Bacteriostatic water is a possible vehicle rather than a universal solvent for the entire catalogue.
In short
Bacteriostatic water is water with a preservative that limits microbial growth; it is not a universal solvent and does not sterilize a contaminated sample. This reference explains how to choose between water, a buffer and bacteriostatic water, plan a small pilot preparation before the main one, calculate the concentration and the vehicle fraction, and what to record after reconstitution.
Identify what needs dissolving
A lyophilisate can contain counterions, residual water or excipients alongside the named substance. A protein construct requires its formulation and activity definition; a small molecule requires its exact chemical form. Do not automatically apply a water-soluble peptide protocol to an antibody, extract or hydrophobic small molecule.
Check the LOT, SDS and supplier's documented method. Record solvent, concentration, mixing conditions, working matrix and allowable time before analysis. If a source specifies a particular pH or sonication, quoting the solubility number without those conditions is incomplete. Bachem's general guidance relates dissolution to peptide structure. [1]
Water, buffer and bacteriostatic water serve different purposes
Water is a solvent but does not itself maintain a specified pH after substance addition. A buffer helps control pH over a defined range, while its components can also influence an assay. Bacteriostatic water contains the preservative specified on its label. Preservative presence does not establish compatibility with living cells, an enzyme or a receptor assay.
The vehicle's status does not transfer to the whole prepared system. Even if water characteristics are established, containers, dry material and the procedure remain separate possible contamination sources. The labelled in-use period of an opened solvent vial also does not establish the shelf life of a peptide dissolved in it.
Plan a small pilot preparation
Choose a pilot volume sufficient for the intended checks. Before opening a cold dry vial, allow it to reach room temperature while sealed; this reduces condensation onto hygroscopic material. Bachem gives this advice for handling lyophilised peptides. [1]
Record the actual vehicle volume and mixing procedure. Vigorous shaking, heating or pH adjustment should not become an undocumented extra step. If the pilot does not dissolve, investigate concentration, chemical form, vehicle and matrix compatibility. Repeatedly adding new solvents creates a mixture whose properties have not been established.
Check the final solution as well as the stock
A clear concentrated stock can lose dissolved material when heavily diluted into a salt-containing medium. Compare appearance and quantitative recovery after transfer into the working matrix and again after the planned exposure. The absence of visible precipitate does not prove that the entire stated mass remains dissolved.
For cell assays, include a separate vehicle control. Record medium composition, protein supplements, final organic solvent fraction and addition order. Culture conditions themselves affect results; ATCC explains why additive and contamination control belong in reproducible cell work. [2]
Calculate substance concentration and vehicle fraction separately
Bringing 10 mg to a final 4 mL gives a nominal mass concentration of 2.5 mg/mL. Transferring 40 microlitres into a final 1 mL gives 0.1 mg/mL. This is an arithmetic example rather than a preparation recommendation for a substance.
If the original stock contained 100% organic vehicle, the final fraction would be 40/1000 × 100% = 4%. The method determines whether that is acceptable. If the starting stock instead contained 10% of that vehicle, the final fraction would be 0.4%. Identical substance concentrations do not imply identical solvent fractions; record both quantities.
Common situations after preparation
| Observation | What to examine |
|---|---|
| Precipitate appears only after dilution | Final matrix, pH, mixing order and the dissolved fraction. |
| Weak signal without visible precipitate | Recovery, transfers, vehicle control and method suitability. |
| Clarity changes during storage | Temperature history, vehicle, new analytical peaks or activity changes. |
| Two batches give different results | Identity, actual content, excipients and preparation consistency. |
Filtration is not a universal repair: some substance can be lost together with particles. If the method requires a filter, verify its material and recovery separately. Do not automatically treat the filtrate as equivalent to the original solution.
Record what happened after reconstitution
Label stock identity, LOT, vehicle, concentration, preparation date and time, storage conditions and protocol reference. Add volume and purpose to aliquot labels. Distinguish dry material, concentrated stock and working dilution because their allowable holding periods can differ.
Long storage is generally planned around the dry peptide rather than a large unvalidated solution stock. See storage and shelf life. Use each molecule's individual guide; calculations and unit checks are explained in the solution preparation reference.
Frequently asked questions
Can water be selected from the peptide name alone? No. The specific form, concentration and final assay are needed. Another manufacturer's data may help design a check, but do not replace the supplied batch specification.
Does a preservative guarantee a month of storage? No. Inhibiting particular microorganisms and maintaining chemical stability are different questions. A solution holding time needs appropriate supporting data.
How much bacteriostatic water should be added to a vial? There is no universal volume: it follows from the target concentration – the mass of substance divided by the final solution volume. Set the target concentration first and derive the volume from it; the solution preparation reference explains the calculations and unit checks.
How does bacteriostatic water differ from sterile water for injection? By the preservative: bacteriostatic water contains an additive that limits microbial growth, sterile water for injection does not; that is why bacteriostatic water is not the default solvent for every method (see the section on the different purposes of water, buffer and bacteriostatic water).
End of article